Nebulizers Market Analysis | United States | 2017-2023 | MedCore

Nebulizers Market Analysis | United States | 2017-2023 | MedCore

0

The market for nebulizers typically contains a compressor and a nebulizer cup. The nebulizer device can be categorized as a “compressor” version which is either a tabletop type and requires be plugging in and typically utilizing at home while there is a more costly hand-held version that is battery powered and used on the go. Alternatively, there are ultrasonic and vibrating mesh nebulizers which achieve transformation of medicine to liquid with high frequency sound waves.

  • Year: 2017
  • Scope: 2013-2023
  • Region: United States
  • Published Date: 7/1/2017
  • Pages: 234
  • Type: MedCore

General Report Contents
– Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
– Market Drivers & Limiters for each chapter segment
– Competitive Analysis for each chapter segment
– Section on recent mergers & acquisitions
A nebulizer is a piece of equipment used to assist breathing in the case that the lung is being affected with diseases such as asthma, cystic fibrosis and other respiratory conditions. The market for nebulizers typically corresponds to the delivery of asthma medications to anyone who has difficulty using a standard asthma inhaler, particularly infants and small children. Medication in liquid form is fed into a nebulizer which it then transforms it into a mist concentration in order to be more easily inhaled into the lungs.
Generally there are two types of nebulizers, either an “atomizer jet” or an “ultrasonic” version. The atomizer jet version is more commonly known as a “compressor nebulizer” and is the standard option available to the market. Compressor nebulizers function through using an aerosol compressor to vaporize droplets of medication. These compressors are effective in delivering formulations that cannot be delivered with pressurized metered-dose inhalers (pMDIs) and dry powder inhalers (DPIs), for instance, antibiotics, mucolytics, liposomal formulations and recombinant products. On the other hand, jet nebulizers can be difficult to use because of their need for compressed gas and additional tubing
Through improvements in the nebulizer design, new jet nebulizers either have reservoirs that conserve aerosols or use baffles that reduce the size of large particles and increase the efficiency of aerosol therapy. They also have breath-enhanced aerosol production that leads to greater drug delivery, a larger fine-particle fraction, and less drug loss during expiration.
Ultrasonic nebulizers incorporate a piezoelectric crystal vibrating at high frequencies in order to produce aerosol. They are divided into two categories: large-volume ultrasonic nebulizers and small-volume ultrasonic nebulizers. Whereas large-volume ultrasonic nebulizers are most commonly used to deliver hypertonic saline for sputum induction, small-volume ultrasonic nebulizers are used for delivery of inhaled medications. Ultrasonic nebulizers have many limitations compared to jet nebulizers. For instance, they have large residual volumes, an inability to aerosolize viscous solutions and degradation of heat-sensitive materials. Therefore, they should not be used with suspensions and proteins



The "US Market Report Suite for Anesthesia, Respiratory and Sleep Management Devices 2017 - MedSuite" includes analysis on the following companies currently active in this market:
Philips Respironics
ResMed
CAIRE Inc.
Becton Dickinson
GE Healthcare
Covidien
DeVilbiss
Invacare
Dr?ger
Teleflex
Fisher & Paykel
Inogen
Smiths Medical
Ambu
Mindray
Omron
Maquet
Westmed
Natus Medical
Others include: Airgas, BD-CareFusion, Cramer Decker, eVent, Flexicare, Flotec, Fukuda Denshi, GE Healthcare, Global Medical Holdings, Graham Field, Intersurgical, Invacare, Mada Medical, Maquet, Massimo, Medis, Mercury Medical, Metal Impact, Nellcor, Nidek, O2 Concepts, Oxlife, Penlon, Percussionaire, Philips Respironics, Sechrist, Somnostar, Spacelabs, SunMed, Teleflex, Ventlab, VisionAire, Welch Allyn, Zoll, etc.
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology


close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link